Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Editas
Biotech
Intellia cuts 27% of staff as it takes ax to pipeline
Intellia is axing 27% of its staffers as it tosses out pipeline assets to keep the engine running until a potential commercial launch in 2027.
Ben Adams
Jan 10, 2025 4:00am
Fierce 15: Where are they now?
Jul 26, 2024 6:50am
Madrigal COO departs days after new CEO starts—Chutes & Ladders
Sep 29, 2023 9:30am
Peter Marks: Gene editing has met regulatory reality
Jul 31, 2023 3:14pm
Roche taps new CEO—Chutes & Ladders
Jul 22, 2022 9:30am
Editas gets good news in form of pediatric disease tag
Apr 26, 2022 11:03am
